STAT

Opinion: Health care needs less #innovation

Health care, famously resistant to change, suddenly can't stop innovating — or at least saying it is. But the industry needs less #innovation and more imitation.

Health care has caught the innovation bug.

An industry famously resistant to change suddenly can’t stop innovating — or at least saying it is. Silicon Valley startups are disrupting health care. Academic medical centers are transforming it. Insurers are revolutionizing medicine and there are any number of conferences devoted to health care innovation. Even the federal government wants in on the action.

Meanwhile, the U.S. health system is unable to safely and consistently provide some of the most basic elements of care. It struggles with massive discrepancies in quality, cost, and outcomes across the country — and performs worse than nearly all.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.

Related Books & Audiobooks